Brain Cancer
175
29
40
88
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
34 trials with published results (19%)
Research Maturity
88 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
25 terminated out of 175 trials
77.9%
-8.6% vs benchmark
6%
10 trials in Phase 3/4
39%
34 of 88 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 88 completed trials
Clinical Trials (175)
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease